No Data
No Data
BD's (BDX) New Research Tool to Aid Single-Cell Analysis
With Becton, Dickinson and Company (NYSE:BDX) It Looks Like You'll Get What You Pay For
Becton, Dickinson and Company's (NYSE:BDX) price-to-earnings (or "P/E") ratio of 49.1x might make it look like a strong sell right now compared to the market in the United States, where around half of
BD Has Commercially Launched New Single-cell Research Tool To Help Scientists Better Understand How Molecular Machinery Within A Cell Functions And It Regulates Changes That Can Lead To Cancer And Other Diseases
BD Has Commercially Launched New Single-cell Research Tool To Help Scientists Better Understand How Molecular Machinery Within A Cell Functions And It Regulates Changes That Can Lead To Cancer And Oth
New BD Research Tool Helps Scientists Study Cells That Are Often Key Culprits in the Development of Cancer and Infectious Diseases
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial launch of a new single-cell...
BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to...
Express News | Bd : Evercore ISI Raises Target Price to $290 From $282